世界の視神経治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Neuromyelitis Optica Therapy Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5882
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、107ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、視神経治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（糖質コルチコイド、免疫療法、その他）、用途別市場規模（急性発作、寛解予防治療）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・視神経治療の市場動向
・企業の競争状況、市場シェア
・視神経治療の種類別市場規模と予測2016-2027（糖質コルチコイド、免疫療法、その他）
・視神経治療の用途別市場規模と予測2016-2027（急性発作、寛解予防治療）
・視神経治療の北米市場規模2016-2027（アメリカ、カナダ）
・視神経治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・視神経治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・視神経治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・視神経治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、Fresenius、Teva、Sandoz、Intas、Gyjtrs、NANG KUANG、Tianjin Kingyork、Baxter、CSL、Grifols、Octapharma、CBOP）
・結論

Neuromyelitis optica (NMO) is an uncommon disease syndrome of the central nervous system (CNS) that affects the optic nerves and spinal cord. Individuals with NMO develop optic neuritis, which causes pain in the eye and vision loss, and transverse myelitis, which causes weakness, numbness, and sometimes paralysis of the arms and legs, along with sensory disturbances and loss of bladder and bowel control. NMO leads to loss of myelin, which is a fatty substance that surrounds nerve fibers and helps nerve signals, move from cell to cell. The syndrome can also damage nerve fibers and leave areas of broken-down tissue. In the disease process of NMO, for reasons that aren’t yet clear, immune system cells and antibodies attack and destroy myelin cells in the optic nerves and the spinal cord.

Market Analysis and Insights: Global Neuromyelitis Optica Therapy Market
The global Neuromyelitis Optica Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Neuromyelitis Optica Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Neuromyelitis Optica Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Neuromyelitis Optica Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Neuromyelitis Optica Therapy market.

Global Neuromyelitis Optica Therapy Scope and Market Size
Neuromyelitis Optica Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Neuromyelitis Optica Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Glucocorticoids
Immunotherapies
Other

Segment by Application
Acute Attack
Remission Prophylactic Treatment

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Fresenius
Teva
Sandoz
Intas
Gyjtrs
NANG KUANG
Tianjin Kingyork
Baxter
CSL
Grifols
Octapharma
CBOP

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuromyelitis Optica Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Glucocorticoids
1.2.3 Immunotherapies
1.2.4 Other
1.3 Market by Application
1.3.1 Global Neuromyelitis Optica Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Acute Attack
1.3.3 Remission Prophylactic Treatment
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Neuromyelitis Optica Therapy Market Perspective (2016-2027)
2.2 Neuromyelitis Optica Therapy Growth Trends by Regions
2.2.1 Neuromyelitis Optica Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Neuromyelitis Optica Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Neuromyelitis Optica Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Neuromyelitis Optica Therapy Industry Dynamic
2.3.1 Neuromyelitis Optica Therapy Market Trends
2.3.2 Neuromyelitis Optica Therapy Market Drivers
2.3.3 Neuromyelitis Optica Therapy Market Challenges
2.3.4 Neuromyelitis Optica Therapy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Neuromyelitis Optica Therapy Players by Revenue
3.1.1 Global Top Neuromyelitis Optica Therapy Players by Revenue (2016-2021)
3.1.2 Global Neuromyelitis Optica Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Neuromyelitis Optica Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Neuromyelitis Optica Therapy Revenue
3.4 Global Neuromyelitis Optica Therapy Market Concentration Ratio
3.4.1 Global Neuromyelitis Optica Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuromyelitis Optica Therapy Revenue in 2020
3.5 Neuromyelitis Optica Therapy Key Players Head office and Area Served
3.6 Key Players Neuromyelitis Optica Therapy Product Solution and Service
3.7 Date of Enter into Neuromyelitis Optica Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Neuromyelitis Optica Therapy Breakdown Data by Type
4.1 Global Neuromyelitis Optica Therapy Historic Market Size by Type (2016-2021)
4.2 Global Neuromyelitis Optica Therapy Forecasted Market Size by Type (2022-2027)

5 Neuromyelitis Optica Therapy Breakdown Data by Application
5.1 Global Neuromyelitis Optica Therapy Historic Market Size by Application (2016-2021)
5.2 Global Neuromyelitis Optica Therapy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Neuromyelitis Optica Therapy Market Size (2016-2027)
6.2 North America Neuromyelitis Optica Therapy Market Size by Type
6.2.1 North America Neuromyelitis Optica Therapy Market Size by Type (2016-2021)
6.2.2 North America Neuromyelitis Optica Therapy Market Size by Type (2022-2027)
6.2.3 North America Neuromyelitis Optica Therapy Market Size by Type (2016-2027)
6.3 North America Neuromyelitis Optica Therapy Market Size by Application
6.3.1 North America Neuromyelitis Optica Therapy Market Size by Application (2016-2021)
6.3.2 North America Neuromyelitis Optica Therapy Market Size by Application (2022-2027)
6.3.3 North America Neuromyelitis Optica Therapy Market Size by Application (2016-2027)
6.4 North America Neuromyelitis Optica Therapy Market Size by Country
6.4.1 North America Neuromyelitis Optica Therapy Market Size by Country (2016-2021)
6.4.2 North America Neuromyelitis Optica Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Neuromyelitis Optica Therapy Market Size (2016-2027)
7.2 Europe Neuromyelitis Optica Therapy Market Size by Type
7.2.1 Europe Neuromyelitis Optica Therapy Market Size by Type (2016-2021)
7.2.2 Europe Neuromyelitis Optica Therapy Market Size by Type (2022-2027)
7.2.3 Europe Neuromyelitis Optica Therapy Market Size by Type (2016-2027)
7.3 Europe Neuromyelitis Optica Therapy Market Size by Application
7.3.1 Europe Neuromyelitis Optica Therapy Market Size by Application (2016-2021)
7.3.2 Europe Neuromyelitis Optica Therapy Market Size by Application (2022-2027)
7.3.3 Europe Neuromyelitis Optica Therapy Market Size by Application (2016-2027)
7.4 Europe Neuromyelitis Optica Therapy Market Size by Country
7.4.1 Europe Neuromyelitis Optica Therapy Market Size by Country (2016-2021)
7.4.2 Europe Neuromyelitis Optica Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Neuromyelitis Optica Therapy Market Size (2016-2027)
8.2 Asia-Pacific Neuromyelitis Optica Therapy Market Size by Type
8.2.1 Asia-Pacific Neuromyelitis Optica Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Neuromyelitis Optica Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Neuromyelitis Optica Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Neuromyelitis Optica Therapy Market Size by Application
8.3.1 Asia-Pacific Neuromyelitis Optica Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Neuromyelitis Optica Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Neuromyelitis Optica Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Neuromyelitis Optica Therapy Market Size by Region
8.4.1 Asia-Pacific Neuromyelitis Optica Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Neuromyelitis Optica Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Neuromyelitis Optica Therapy Market Size (2016-2027)
9.2 Latin America Neuromyelitis Optica Therapy Market Size by Type
9.2.1 Latin America Neuromyelitis Optica Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Neuromyelitis Optica Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Neuromyelitis Optica Therapy Market Size by Type (2016-2027)
9.3 Latin America Neuromyelitis Optica Therapy Market Size by Application
9.3.1 Latin America Neuromyelitis Optica Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Neuromyelitis Optica Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Neuromyelitis Optica Therapy Market Size by Application (2016-2027)
9.4 Latin America Neuromyelitis Optica Therapy Market Size by Country
9.4.1 Latin America Neuromyelitis Optica Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Neuromyelitis Optica Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Neuromyelitis Optica Therapy Market Size (2016-2027)
10.2 Middle East & Africa Neuromyelitis Optica Therapy Market Size by Type
10.2.1 Middle East & Africa Neuromyelitis Optica Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Neuromyelitis Optica Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Neuromyelitis Optica Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Neuromyelitis Optica Therapy Market Size by Application
10.3.1 Middle East & Africa Neuromyelitis Optica Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Neuromyelitis Optica Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Neuromyelitis Optica Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Neuromyelitis Optica Therapy Market Size by Country
10.4.1 Middle East & Africa Neuromyelitis Optica Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Neuromyelitis Optica Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Neuromyelitis Optica Therapy Introduction
11.1.4 Pfizer Revenue in Neuromyelitis Optica Therapy Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Fresenius
11.2.1 Fresenius Company Details
11.2.2 Fresenius Business Overview
11.2.3 Fresenius Neuromyelitis Optica Therapy Introduction
11.2.4 Fresenius Revenue in Neuromyelitis Optica Therapy Business (2016-2021)
11.2.5 Fresenius Recent Development
11.3 Teva
11.3.1 Teva Company Details
11.3.2 Teva Business Overview
11.3.3 Teva Neuromyelitis Optica Therapy Introduction
11.3.4 Teva Revenue in Neuromyelitis Optica Therapy Business (2016-2021)
11.3.5 Teva Recent Development
11.4 Sandoz
11.4.1 Sandoz Company Details
11.4.2 Sandoz Business Overview
11.4.3 Sandoz Neuromyelitis Optica Therapy Introduction
11.4.4 Sandoz Revenue in Neuromyelitis Optica Therapy Business (2016-2021)
11.4.5 Sandoz Recent Development
11.5 Intas
11.5.1 Intas Company Details
11.5.2 Intas Business Overview
11.5.3 Intas Neuromyelitis Optica Therapy Introduction
11.5.4 Intas Revenue in Neuromyelitis Optica Therapy Business (2016-2021)
11.5.5 Intas Recent Development
11.6 Gyjtrs
11.6.1 Gyjtrs Company Details
11.6.2 Gyjtrs Business Overview
11.6.3 Gyjtrs Neuromyelitis Optica Therapy Introduction
11.6.4 Gyjtrs Revenue in Neuromyelitis Optica Therapy Business (2016-2021)
11.6.5 Gyjtrs Recent Development
11.7 NANG KUANG
11.7.1 NANG KUANG Company Details
11.7.2 NANG KUANG Business Overview
11.7.3 NANG KUANG Neuromyelitis Optica Therapy Introduction
11.7.4 NANG KUANG Revenue in Neuromyelitis Optica Therapy Business (2016-2021)
11.7.5 NANG KUANG Recent Development
11.8 Tianjin Kingyork
11.8.1 Tianjin Kingyork Company Details
11.8.2 Tianjin Kingyork Business Overview
11.8.3 Tianjin Kingyork Neuromyelitis Optica Therapy Introduction
11.8.4 Tianjin Kingyork Revenue in Neuromyelitis Optica Therapy Business (2016-2021)
11.8.5 Tianjin Kingyork Recent Development
11.9 Baxter
11.9.1 Baxter Company Details
11.9.2 Baxter Business Overview
11.9.3 Baxter Neuromyelitis Optica Therapy Introduction
11.9.4 Baxter Revenue in Neuromyelitis Optica Therapy Business (2016-2021)
11.9.5 Baxter Recent Development
11.10 CSL
11.10.1 CSL Company Details
11.10.2 CSL Business Overview
11.10.3 CSL Neuromyelitis Optica Therapy Introduction
11.10.4 CSL Revenue in Neuromyelitis Optica Therapy Business (2016-2021)
11.10.5 CSL Recent Development
11.11 Grifols
11.11.1 Grifols Company Details
11.11.2 Grifols Business Overview
11.11.3 Grifols Neuromyelitis Optica Therapy Introduction
11.11.4 Grifols Revenue in Neuromyelitis Optica Therapy Business (2016-2021)
11.11.5 Grifols Recent Development
11.12 Octapharma
11.12.1 Octapharma Company Details
11.12.2 Octapharma Business Overview
11.12.3 Octapharma Neuromyelitis Optica Therapy Introduction
11.12.4 Octapharma Revenue in Neuromyelitis Optica Therapy Business (2016-2021)
11.12.5 Octapharma Recent Development
11.13 CBOP
11.13.1 CBOP Company Details
11.13.2 CBOP Business Overview
11.13.3 CBOP Neuromyelitis Optica Therapy Introduction
11.13.4 CBOP Revenue in Neuromyelitis Optica Therapy Business (2016-2021)
11.13.5 CBOP Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Neuromyelitis Optica Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Glucocorticoids
Table 3. Key Players of Immunotherapies
Table 4. Key Players of Other
Table 5. Global Neuromyelitis Optica Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Neuromyelitis Optica Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Neuromyelitis Optica Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Neuromyelitis Optica Therapy Market Share by Regions (2016-2021)
Table 9. Global Neuromyelitis Optica Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Neuromyelitis Optica Therapy Market Share by Regions (2022-2027)
Table 11. Neuromyelitis Optica Therapy Market Trends
Table 12. Neuromyelitis Optica Therapy Market Drivers
Table 13. Neuromyelitis Optica Therapy Market Challenges
Table 14. Neuromyelitis Optica Therapy Market Restraints
Table 15. Global Neuromyelitis Optica Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Neuromyelitis Optica Therapy Market Share by Players (2016-2021)
Table 17. Global Top Neuromyelitis Optica Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuromyelitis Optica Therapy as of 2020)
Table 18. Ranking of Global Top Neuromyelitis Optica Therapy Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Neuromyelitis Optica Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Neuromyelitis Optica Therapy Product Solution and Service
Table 22. Date of Enter into Neuromyelitis Optica Therapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Neuromyelitis Optica Therapy Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Neuromyelitis Optica Therapy Revenue Market Share by Type (2016-2021)
Table 26. Global Neuromyelitis Optica Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Neuromyelitis Optica Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Neuromyelitis Optica Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Neuromyelitis Optica Therapy Revenue Market Share by Application (2016-2021)
Table 30. Global Neuromyelitis Optica Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Neuromyelitis Optica Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Neuromyelitis Optica Therapy Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Neuromyelitis Optica Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Neuromyelitis Optica Therapy Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Neuromyelitis Optica Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Neuromyelitis Optica Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Neuromyelitis Optica Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Neuromyelitis Optica Therapy Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Neuromyelitis Optica Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Neuromyelitis Optica Therapy Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Neuromyelitis Optica Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Neuromyelitis Optica Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Neuromyelitis Optica Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Neuromyelitis Optica Therapy Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Neuromyelitis Optica Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Neuromyelitis Optica Therapy Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Neuromyelitis Optica Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Neuromyelitis Optica Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Neuromyelitis Optica Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Neuromyelitis Optica Therapy Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Neuromyelitis Optica Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Neuromyelitis Optica Therapy Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Neuromyelitis Optica Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Neuromyelitis Optica Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Neuromyelitis Optica Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Neuromyelitis Optica Therapy Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Neuromyelitis Optica Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Neuromyelitis Optica Therapy Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Neuromyelitis Optica Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Neuromyelitis Optica Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Neuromyelitis Optica Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Neuromyelitis Optica Therapy Product
Table 65. Pfizer Revenue in Neuromyelitis Optica Therapy Business (2016-2021) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. Fresenius Company Details
Table 68. Fresenius Business Overview
Table 69. Fresenius Neuromyelitis Optica Therapy Product
Table 70. Fresenius Revenue in Neuromyelitis Optica Therapy Business (2016-2021) & (US$ Million)
Table 71. Fresenius Recent Development
Table 72. Teva Company Details
Table 73. Teva Business Overview
Table 74. Teva Neuromyelitis Optica Therapy Product
Table 75. Teva Revenue in Neuromyelitis Optica Therapy Business (2016-2021) & (US$ Million)
Table 76. Teva Recent Development
Table 77. Sandoz Company Details
Table 78. Sandoz Business Overview
Table 79. Sandoz Neuromyelitis Optica Therapy Product
Table 80. Sandoz Revenue in Neuromyelitis Optica Therapy Business (2016-2021) & (US$ Million)
Table 81. Sandoz Recent Development
Table 82. Intas Company Details
Table 83. Intas Business Overview
Table 84. Intas Neuromyelitis Optica Therapy Product
Table 85. Intas Revenue in Neuromyelitis Optica Therapy Business (2016-2021) & (US$ Million)
Table 86. Intas Recent Development
Table 87. Gyjtrs Company Details
Table 88. Gyjtrs Business Overview
Table 89. Gyjtrs Neuromyelitis Optica Therapy Product
Table 90. Gyjtrs Revenue in Neuromyelitis Optica Therapy Business (2016-2021) & (US$ Million)
Table 91. Gyjtrs Recent Development
Table 92. NANG KUANG Company Details
Table 93. NANG KUANG Business Overview
Table 94. NANG KUANG Neuromyelitis Optica Therapy Product
Table 95. NANG KUANG Revenue in Neuromyelitis Optica Therapy Business (2016-2021) & (US$ Million)
Table 96. NANG KUANG Recent Development
Table 97. Tianjin Kingyork Company Details
Table 98. Tianjin Kingyork Business Overview
Table 99. Tianjin Kingyork Revenue in Neuromyelitis Optica Therapy Business (2016-2021) & (US$ Million)
Table 100. Tianjin Kingyork Recent Development
Table 101. Baxter Company Details
Table 102. Baxter Business Overview
Table 103. Baxter Neuromyelitis Optica Therapy Product
Table 104. Baxter Revenue in Neuromyelitis Optica Therapy Business (2016-2021) & (US$ Million)
Table 105. Baxter Recent Development
Table 106. CSL Company Details
Table 107. CSL Business Overview
Table 108. CSL Neuromyelitis Optica Therapy Product
Table 109. CSL Revenue in Neuromyelitis Optica Therapy Business (2016-2021) & (US$ Million)
Table 110. CSL Recent Development
Table 111. Grifols Company Details
Table 112. Grifols Business Overview
Table 113. Grifols Neuromyelitis Optica Therapy Product
Table 114. Grifols Revenue in Neuromyelitis Optica Therapy Business (2016-2021) & (US$ Million)
Table 115. Grifols Recent Development
Table 116. Octapharma Company Details
Table 117. Octapharma Business Overview
Table 118. Octapharma Neuromyelitis Optica Therapy Product
Table 119. Octapharma Revenue in Neuromyelitis Optica Therapy Business (2016-2021) & (US$ Million)
Table 120. Octapharma Recent Development
Table 121. CBOP Company Details
Table 122. CBOP Business Overview
Table 123. CBOP Neuromyelitis Optica Therapy Product
Table 124. CBOP Revenue in Neuromyelitis Optica Therapy Business (2016-2021) & (US$ Million)
Table 125. CBOP Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neuromyelitis Optica Therapy Market Share by Type: 2020 VS 2027
Figure 2. Glucocorticoids Features
Figure 3. Immunotherapies Features
Figure 4. Other Features
Figure 5. Global Neuromyelitis Optica Therapy Market Share by Application: 2020 VS 2027
Figure 6. Acute Attack Case Studies
Figure 7. Remission Prophylactic Treatment Case Studies
Figure 8. Neuromyelitis Optica Therapy Report Years Considered
Figure 9. Global Neuromyelitis Optica Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Neuromyelitis Optica Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Neuromyelitis Optica Therapy Market Share by Regions: 2020 VS 2027
Figure 12. Global Neuromyelitis Optica Therapy Market Share by Regions (2022-2027)
Figure 13. Global Neuromyelitis Optica Therapy Market Share by Players in 2020
Figure 14. Global Top Neuromyelitis Optica Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuromyelitis Optica Therapy as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Neuromyelitis Optica Therapy Revenue in 2020
Figure 16. Global Neuromyelitis Optica Therapy Revenue Market Share by Type (2016-2021)
Figure 17. Global Neuromyelitis Optica Therapy Revenue Market Share by Type (2022-2027)
Figure 18. North America Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Neuromyelitis Optica Therapy Market Share by Type (2016-2027)
Figure 20. North America Neuromyelitis Optica Therapy Market Share by Application (2016-2027)
Figure 21. North America Neuromyelitis Optica Therapy Market Share by Country (2016-2027)
Figure 22. United States Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Neuromyelitis Optica Therapy Market Share by Type (2016-2027)
Figure 26. Europe Neuromyelitis Optica Therapy Market Share by Application (2016-2027)
Figure 27. Europe Neuromyelitis Optica Therapy Market Share by Country (2016-2027)
Figure 28. Germany Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Neuromyelitis Optica Therapy Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Neuromyelitis Optica Therapy Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Neuromyelitis Optica Therapy Market Share by Region (2016-2027)
Figure 38. China Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Neuromyelitis Optica Therapy Market Share by Type (2016-2027)
Figure 46. Latin America Neuromyelitis Optica Therapy Market Share by Application (2016-2027)
Figure 47. Latin America Neuromyelitis Optica Therapy Market Share by Country (2016-2027)
Figure 48. Mexico Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Neuromyelitis Optica Therapy Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Neuromyelitis Optica Therapy Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Neuromyelitis Optica Therapy Market Share by Country (2016-2027)
Figure 54. Turkey Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Neuromyelitis Optica Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Pfizer Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2016-2021)
Figure 58. Fresenius Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2016-2021)
Figure 59. Teva Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2016-2021)
Figure 60. Sandoz Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2016-2021)
Figure 61. Intas Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2016-2021)
Figure 62. Gyjtrs Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2016-2021)
Figure 63. NANG KUANG Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2016-2021)
Figure 64. Tianjin Kingyork Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2016-2021)
Figure 65. Baxter Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2016-2021)
Figure 66. CSL Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2016-2021)
Figure 67. Grifols Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2016-2021)
Figure 68. Octapharma Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2016-2021)
Figure 69. CBOP Revenue Growth Rate in Neuromyelitis Optica Therapy Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size, Status and Forecast 2021-2027
QFJ1-4571 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、視神経スペクトラム障害（NMOSD）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（静脈注射、経口、皮下、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州...

世界のデビック症候群（視神経脊髄炎）治療市場規模・現状・予測（2021年-2027年）

Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4118 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、デビック症候群（視神経脊髄炎）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エクリズマブ、メチルプレドニゾロン、アザチオプリン、ミコフェノール酸モフェチル、リツキシマブ）、用途別市場規模（病院、...

世界の重粒子線治療市場規模・現状・予測（2021年-2027年）

Global Heavy Ion Therapy Market Size, Status and Forecast 2021-2027
QFJ1-5188 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、重粒子線治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（機器、サービス）、用途別市場規模（科学研究所、医療、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界の補助療法市場規模・現状・予測（2021年-2027年）

Global Adjuvant Therapy Market Size, Status and Forecast 2021-2027
QFJ1-3765 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、補助療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、ホルモン療法、その他）、用途別市場規模（病院、医療機関、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のTCR-T療法試薬市場規模・現状・予測（2021年-2027年）

Global TCR-T Therapy Reagent Market Size, Status and Forecast 2021-2027
QFJ1-4940 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、TCR-T療法試薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（血清試薬、抗体試薬、タンパク質試薬、その他）、用途別市場規模（病院、バイオラボ、その他）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界のパラフィン理学療法市場規模・現状・予測（2021年-2027年）

Global Paraffin Physical Therapy Market Size, Status and Forecast 2021-2027
QFJ1-4653 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、パラフィン理学療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（即時使用可能パラフィン理学療法、即時加熱可能パラフィン理学療法）、用途別市場規模（病院、クリニック、若返りセンター）、主要地域別市場規...

世界の時差ボケ治療薬市場規模・現状・予測（2021年-2027年）

Global Jet Lag Therapy Pharmaceuticals Market Size, Status and Forecast 2021-2027
QFJ1-5816 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、時差ボケ治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（Rx、OTC）、用途別市場規模（ビジネス旅行者、キャビンクルー、アスリート、季節旅行者、その他）、主要地域別市場規模（北米、アメリカ、欧州...

世界の神経再生治療市場規模・現状・予測（2021年-2027年）

Global Neuroregeneration Therapy Market Size, Status and Forecast 2021-2027
QFJ1-4573 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、神経再生治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（末梢神経系の再生、中枢神経系の再生、軸索の再生の阻害）、用途別市場規模（病院、クリニック、研究機関）、主要地域別市場規模（北米、アメリカ、欧...

世界のTIL療法市場規模・現状・予測（2021年-2027年）

Global TIL Therapy Market Size, Status and Forecast 2021-2027
QFJ1-4957 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、TIL療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（単回注入、複数回注入）、用途別市場規模（胃がん、膵臓がん、肝細胞がん、子宮/子宮内膜がん、子宮頸がん、尿道がん、腎細胞がん、その他）、主要地域...

世界の自己細胞療法市場規模・現状・予測（2021年-2027年）

Global Autologous Cell Therapy Market Size, Status and Forecast 2021-2027
QFJ1-3873 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、自己細胞療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（骨髄、表皮）、用途別市場規模（神経内科、整形外科、がん、創傷治癒、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界のデビック症候群（視神経脊髄炎）治療市場規模・現状・予測（2021年-2027年） Devic’s syndrome is also known as neuromyelitis optica which is a central nervous system disorder that specifically affects eye nerves and spinal cord. Market Analysis and Insights: Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Market The global Devic’s Syndrome (Neuromyelitis Optica) Tre…
世界の視神経スペクトラム障害（NMOSD）市場規模・現状・予測（2021年-2027年） Neuromyelitis optica spectrum disorder (NMOSD), also known as Devic disease, is a chronic disorder of the brain and spinal cord dominated by inflammation of the optic nerve (optic neuritis) and the spinal cord (myelitis). Classically, it was felt to be a monophasic illness, consisting of episodes of…
世界の重粒子線治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Heavy Ion Therapy Market The global Heavy Ion Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a…
世界の圧迫衣類療法市場規模・現状・予測（2021年-2027年） The presence of a large number of target patients and the rising incidence of sports injuries and accidents are the main factors driving the growth of the compression therapy market. Based on products, the compression therapy market is segmented into compression garments, compression correctors and …
世界の補助療法市場規模・現状・予測（2021年-2027年） Adjuvant therapy is defined as the treatment given in addition to the primary (initial) treatment. In other words it is an additional treatment that is designed to help to reach the ultimate goal. Market Analysis and Insights: Global Adjuvant Therapy Market The global Adjuvant Therapy market size is…